We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LE icon
4276
Lands' End
LE
$403M
$9K ﹤0.01%
891
-14,497
-94% -$190K
TCRT icon
4277
Alaunos Therapeutics
TCRT
$4.86M
$9K ﹤0.01%
50
-241
-83% -$23K
TMCI icon
4278
Treace Medical Concepts
TMCI
$309M
$9K ﹤0.01%
601
-2,077
-78% -$35K
ASXC
4279
DELISTED
Asensus Surgical, Inc.
ASXC
$9K ﹤0.01%
+21,643
New +$9.66K
ROCLW
4280
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$8K ﹤0.01%
47,227
-212,027
-82% -$61.6K
CZOO
4281
DELISTED
Cazoo Group Ltd
CZOO
$8K ﹤0.01%
6
-3
-33% -$9.88K
ARCKW
4282
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$8K ﹤0.01%
132,748
– –
ALV icon
4283
Autoliv
ALV
$9B
$7K ﹤0.01%
96
-87,657
-100% -$6.55M
AMWL icon
4284
American Well
AMWL
$230M
$7K ﹤0.01%
79
-10,708
-99% -$799K
LITS
4285
Lite Strategy Inc
LITS
$30.9M
$7K ﹤0.01%
+586
New +$6.38K
TXMD icon
4286
TherapeuticsMD
TXMD
$24M
$7K ﹤0.01%
714
+693
+3,300% +$6.62K
UBX
4287
DELISTED
Unity Biotechnology
UBX
$7K ﹤0.01%
1,156
-3,329
-74% -$27.8K
AKBA icon
4288
Akebia Therapeutics
AKBA
$252M
$6K ﹤0.01%
+18,295
New +$7.68K
EBON icon
4289
Ebang International Holdings
EBON
$12.3M
$6K ﹤0.01%
+521
New +$12.7K
TERN
4290
DELISTED
Terns Pharmaceuticals
TERN
$6K ﹤0.01%
2,428
+1,228
+102% +$2.45K
CFFSW
4291
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$6K ﹤0.01%
39,089
-29,092
-43% -$9.42K
VBIV
4292
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$6K ﹤0.01%
227
-123
-35% -$4.19K
TRVN
4293
DELISTED
Trevena, Inc.
TRVN
$6K ﹤0.01%
+24
New +$5.28K
HARP
4294
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6K ﹤0.01%
321
-1,534
-83% -$39.7K
ATHX
4295
DELISTED
Athersys, Inc. Common Stock
ATHX
$6K ﹤0.01%
+943
New +$10.4K
ALGS icon
4296
Aligos Therapeutics
ALGS
$34.9M
$5K ﹤0.01%
154
-63
-29% -$2.14K
ARDX icon
4297
Ardelyx
ARDX
$997M
$5K ﹤0.01%
8,889
-227,500
-96% -$168K
IBIO icon
4298
iBio
IBIO
$70M
$5K ﹤0.01%
+40
New +$6.01K
MACK
4299
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$5K ﹤0.01%
800
+432
+117% +$2.44K
ADAP
4300
DELISTED
Adaptimmune Therapeutics
ADAP
$4K ﹤0.01%
2,094
-42,106
-95% -$72.3K
170 171
172
173 174

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.